Renal cell carcinoma (RCC) is increasing in incidence and one third of newly diagnosed cases already are metastatic. The metastatic spread of solid tumors renders RCC incurable by surgical resection and consequently more difficult to treat. New molecular-targeted therapies have played a pivotal role in RCC treatment.
This report aims to provide a comprehensive presentation of the global market for Renal Cell Carcinoma Therapy Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Cell Carcinoma Therapy Devices. This report contains market size and forecasts of Renal Cell Carcinoma Therapy Devices in global, including the following market information:
Global Renal Cell Carcinoma Therapy Devices Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Renal Cell Carcinoma Therapy Devices market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Directed Energy-based Therapy Devices Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Renal Cell Carcinoma Therapy Devices include AngioDynamics, Inc., Boston Scientific Corporation (Galil Medical, Inc.), IceCure Medical, HealthTronics, Inc., HistoSonics, Inc., Integra LifeSciences Holdings Corporation, Medtronic plc, Monteris Medical, Inc. and Novocure GmbH, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Renal Cell Carcinoma Therapy Devices companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Renal Cell Carcinoma Therapy Devices Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Renal Cell Carcinoma Therapy Devices Market Segment Percentages, by Type, 2022 (%)
Directed Energy-based Therapy Devices
Drug/Fluid Delivery and Infusion Therapy Devices
Global Renal Cell Carcinoma Therapy Devices Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Renal Cell Carcinoma Therapy Devices Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Global Renal Cell Carcinoma Therapy Devices Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Renal Cell Carcinoma Therapy Devices Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Renal Cell Carcinoma Therapy Devices revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Renal Cell Carcinoma Therapy Devices revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AngioDynamics, Inc.
Boston Scientific Corporation (Galil Medical, Inc.)
IceCure Medical
HealthTronics, Inc.
HistoSonics, Inc.
Integra LifeSciences Holdings Corporation
Medtronic plc
Monteris Medical, Inc.
Novocure GmbH
Varian Medical Systems, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Renal Cell Carcinoma Therapy Devices, market overview.
Chapter 2: Global Renal Cell Carcinoma Therapy Devices market size in revenue.
Chapter 3: Detailed analysis of Renal Cell Carcinoma Therapy Devices company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Renal Cell Carcinoma Therapy Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Renal Cell Carcinoma Therapy Devices Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Renal Cell Carcinoma Therapy Devices Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Renal Cell Carcinoma Therapy Devices Overall Market Size
2.1 Global Renal Cell Carcinoma Therapy Devices Market Size: 2022 VS 2030
2.2 Global Renal Cell Carcinoma Therapy Devices Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Renal Cell Carcinoma Therapy Devices Players in Global Market
3.2 Top Global Renal Cell Carcinoma Therapy Devices Companies Ranked by Revenue
3.3 Global Renal Cell Carcinoma Therapy Devices Revenue by Companies
3.4 Top 3 and Top 5 Renal Cell Carcinoma Therapy Devices Companies in Global Market, by Revenue in 2022
3.5 Global Companies Renal Cell Carcinoma Therapy Devices Product Type
3.6 Tier 1, Tier 2 and Tier 3 Renal Cell Carcinoma Therapy Devices Players in Global Market
3.6.1 List of Global Tier 1 Renal Cell Carcinoma Therapy Devices Companies
3.6.2 List of Global Tier 2 and Tier 3 Renal Cell Carcinoma Therapy Devices Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Renal Cell Carcinoma Therapy Devices Market Size Markets, 2022 & 2030
4.1.2 Directed Energy-based Therapy Devices
4.1.3 Drug/Fluid Delivery and Infusion Therapy Devices
4.2 By Type - Global Renal Cell Carcinoma Therapy Devices Revenue & Forecasts
4.2.1 By Type - Global Renal Cell Carcinoma Therapy Devices Revenue, 2018-2023
4.2.2 By Type - Global Renal Cell Carcinoma Therapy Devices Revenue, 2024-2030
4.2.3 By Type - Global Renal Cell Carcinoma Therapy Devices Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Renal Cell Carcinoma Therapy Devices Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.2 By Application - Global Renal Cell Carcinoma Therapy Devices Revenue & Forecasts
5.2.1 By Application - Global Renal Cell Carcinoma Therapy Devices Revenue, 2018-2023
5.2.2 By Application - Global Renal Cell Carcinoma Therapy Devices Revenue, 2024-2030
5.2.3 By Application - Global Renal Cell Carcinoma Therapy Devices Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Renal Cell Carcinoma Therapy Devices Market Size, 2022 & 2030
6.2 By Region - Global Renal Cell Carcinoma Therapy Devices Revenue & Forecasts
6.2.1 By Region - Global Renal Cell Carcinoma Therapy Devices Revenue, 2018-2023
6.2.2 By Region - Global Renal Cell Carcinoma Therapy Devices Revenue, 2024-2030
6.2.3 By Region - Global Renal Cell Carcinoma Therapy Devices Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Renal Cell Carcinoma Therapy Devices Revenue, 2018-2030
6.3.2 US Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.3.3 Canada Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.3.4 Mexico Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Renal Cell Carcinoma Therapy Devices Revenue, 2018-2030
6.4.2 Germany Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.4.3 France Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.4.4 U.K. Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.4.5 Italy Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.4.6 Russia Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.4.7 Nordic Countries Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.4.8 Benelux Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Renal Cell Carcinoma Therapy Devices Revenue, 2018-2030
6.5.2 China Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.5.3 Japan Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.5.4 South Korea Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.5.5 Southeast Asia Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.5.6 India Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Renal Cell Carcinoma Therapy Devices Revenue, 2018-2030
6.6.2 Brazil Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.6.3 Argentina Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Renal Cell Carcinoma Therapy Devices Revenue, 2018-2030
6.7.2 Turkey Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.7.3 Israel Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.7.4 Saudi Arabia Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
6.7.5 UAE Renal Cell Carcinoma Therapy Devices Market Size, 2018-2030
7 Renal Cell Carcinoma Therapy Devices Companies Profiles
7.1 AngioDynamics, Inc.
7.1.1 AngioDynamics, Inc. Company Summary
7.1.2 AngioDynamics, Inc. Business Overview
7.1.3 AngioDynamics, Inc. Renal Cell Carcinoma Therapy Devices Major Product Offerings
7.1.4 AngioDynamics, Inc. Renal Cell Carcinoma Therapy Devices Revenue in Global Market (2018-2023)
7.1.5 AngioDynamics, Inc. Key News & Latest Developments
7.2 Boston Scientific Corporation (Galil Medical, Inc.)
7.2.1 Boston Scientific Corporation (Galil Medical, Inc.) Company Summary
7.2.2 Boston Scientific Corporation (Galil Medical, Inc.) Business Overview
7.2.3 Boston Scientific Corporation (Galil Medical, Inc.) Renal Cell Carcinoma Therapy Devices Major Product Offerings
7.2.4 Boston Scientific Corporation (Galil Medical, Inc.) Renal Cell Carcinoma Therapy Devices Revenue in Global Market (2018-2023)
7.2.5 Boston Scientific Corporation (Galil Medical, Inc.) Key News & Latest Developments
7.3 IceCure Medical
7.3.1 IceCure Medical Company Summary
7.3.2 IceCure Medical Business Overview
7.3.3 IceCure Medical Renal Cell Carcinoma Therapy Devices Major Product Offerings
7.3.4 IceCure Medical Renal Cell Carcinoma Therapy Devices Revenue in Global Market (2018-2023)
7.3.5 IceCure Medical Key News & Latest Developments
7.4 HealthTronics, Inc.
7.4.1 HealthTronics, Inc. Company Summary
7.4.2 HealthTronics, Inc. Business Overview
7.4.3 HealthTronics, Inc. Renal Cell Carcinoma Therapy Devices Major Product Offerings
7.4.4 HealthTronics, Inc. Renal Cell Carcinoma Therapy Devices Revenue in Global Market (2018-2023)
7.4.5 HealthTronics, Inc. Key News & Latest Developments
7.5 HistoSonics, Inc.
7.5.1 HistoSonics, Inc. Company Summary
7.5.2 HistoSonics, Inc. Business Overview
7.5.3 HistoSonics, Inc. Renal Cell Carcinoma Therapy Devices Major Product Offerings
7.5.4 HistoSonics, Inc. Renal Cell Carcinoma Therapy Devices Revenue in Global Market (2018-2023)
7.5.5 HistoSonics, Inc. Key News & Latest Developments
7.6 Integra LifeSciences Holdings Corporation
7.6.1 Integra LifeSciences Holdings Corporation Company Summary
7.6.2 Integra LifeSciences Holdings Corporation Business Overview
7.6.3 Integra LifeSciences Holdings Corporation Renal Cell Carcinoma Therapy Devices Major Product Offerings
7.6.4 Integra LifeSciences Holdings Corporation Renal Cell Carcinoma Therapy Devices Revenue in Global Market (2018-2023)
7.6.5 Integra LifeSciences Holdings Corporation Key News & Latest Developments
7.7 Medtronic plc
7.7.1 Medtronic plc Company Summary
7.7.2 Medtronic plc Business Overview
7.7.3 Medtronic plc Renal Cell Carcinoma Therapy Devices Major Product Offerings
7.7.4 Medtronic plc Renal Cell Carcinoma Therapy Devices Revenue in Global Market (2018-2023)
7.7.5 Medtronic plc Key News & Latest Developments
7.8 Monteris Medical, Inc.
7.8.1 Monteris Medical, Inc. Company Summary
7.8.2 Monteris Medical, Inc. Business Overview
7.8.3 Monteris Medical, Inc. Renal Cell Carcinoma Therapy Devices Major Product Offerings
7.8.4 Monteris Medical, Inc. Renal Cell Carcinoma Therapy Devices Revenue in Global Market (2018-2023)
7.8.5 Monteris Medical, Inc. Key News & Latest Developments
7.9 Novocure GmbH
7.9.1 Novocure GmbH Company Summary
7.9.2 Novocure GmbH Business Overview
7.9.3 Novocure GmbH Renal Cell Carcinoma Therapy Devices Major Product Offerings
7.9.4 Novocure GmbH Renal Cell Carcinoma Therapy Devices Revenue in Global Market (2018-2023)
7.9.5 Novocure GmbH Key News & Latest Developments
7.10 Varian Medical Systems, Inc.
7.10.1 Varian Medical Systems, Inc. Company Summary
7.10.2 Varian Medical Systems, Inc. Business Overview
7.10.3 Varian Medical Systems, Inc. Renal Cell Carcinoma Therapy Devices Major Product Offerings
7.10.4 Varian Medical Systems, Inc. Renal Cell Carcinoma Therapy Devices Revenue in Global Market (2018-2023)
7.10.5 Varian Medical Systems, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Renal Cell Carcinoma Therapy Devices Market Opportunities & Trends in Global Market
Table 2. Renal Cell Carcinoma Therapy Devices Market Drivers in Global Market
Table 3. Renal Cell Carcinoma Therapy Devices Market Restraints in Global Market
Table 4. Key Players of Renal Cell Carcinoma Therapy Devices in Global Market
Table 5. Top Renal Cell Carcinoma Therapy Devices Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Renal Cell Carcinoma Therapy Devices Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Renal Cell Carcinoma Therapy Devices Revenue Share by Companies, 2018-2023
Table 8. Global Companies Renal Cell Carcinoma Therapy Devices Product Type
Table 9. List of Global Tier 1 Renal Cell Carcinoma Therapy Devices Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Renal Cell Carcinoma Therapy Devices Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Renal Cell Carcinoma Therapy Devices Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Renal Cell Carcinoma Therapy Devices Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Renal Cell Carcinoma Therapy Devices Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Renal Cell Carcinoma Therapy Devices Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Renal Cell Carcinoma Therapy Devices Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Renal Cell Carcinoma Therapy Devices Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2024-2030
Table 30. AngioDynamics, Inc. Company Summary
Table 31. AngioDynamics, Inc. Renal Cell Carcinoma Therapy Devices Product Offerings
Table 32. AngioDynamics, Inc. Renal Cell Carcinoma Therapy Devices Revenue (US$, Mn) & (2018-2023)
Table 33. AngioDynamics, Inc. Key News & Latest Developments
Table 34. Boston Scientific Corporation (Galil Medical, Inc.) Company Summary
Table 35. Boston Scientific Corporation (Galil Medical, Inc.) Renal Cell Carcinoma Therapy Devices Product Offerings
Table 36. Boston Scientific Corporation (Galil Medical, Inc.) Renal Cell Carcinoma Therapy Devices Revenue (US$, Mn) & (2018-2023)
Table 37. Boston Scientific Corporation (Galil Medical, Inc.) Key News & Latest Developments
Table 38. IceCure Medical Company Summary
Table 39. IceCure Medical Renal Cell Carcinoma Therapy Devices Product Offerings
Table 40. IceCure Medical Renal Cell Carcinoma Therapy Devices Revenue (US$, Mn) & (2018-2023)
Table 41. IceCure Medical Key News & Latest Developments
Table 42. HealthTronics, Inc. Company Summary
Table 43. HealthTronics, Inc. Renal Cell Carcinoma Therapy Devices Product Offerings
Table 44. HealthTronics, Inc. Renal Cell Carcinoma Therapy Devices Revenue (US$, Mn) & (2018-2023)
Table 45. HealthTronics, Inc. Key News & Latest Developments
Table 46. HistoSonics, Inc. Company Summary
Table 47. HistoSonics, Inc. Renal Cell Carcinoma Therapy Devices Product Offerings
Table 48. HistoSonics, Inc. Renal Cell Carcinoma Therapy Devices Revenue (US$, Mn) & (2018-2023)
Table 49. HistoSonics, Inc. Key News & Latest Developments
Table 50. Integra LifeSciences Holdings Corporation Company Summary
Table 51. Integra LifeSciences Holdings Corporation Renal Cell Carcinoma Therapy Devices Product Offerings
Table 52. Integra LifeSciences Holdings Corporation Renal Cell Carcinoma Therapy Devices Revenue (US$, Mn) & (2018-2023)
Table 53. Integra LifeSciences Holdings Corporation Key News & Latest Developments
Table 54. Medtronic plc Company Summary
Table 55. Medtronic plc Renal Cell Carcinoma Therapy Devices Product Offerings
Table 56. Medtronic plc Renal Cell Carcinoma Therapy Devices Revenue (US$, Mn) & (2018-2023)
Table 57. Medtronic plc Key News & Latest Developments
Table 58. Monteris Medical, Inc. Company Summary
Table 59. Monteris Medical, Inc. Renal Cell Carcinoma Therapy Devices Product Offerings
Table 60. Monteris Medical, Inc. Renal Cell Carcinoma Therapy Devices Revenue (US$, Mn) & (2018-2023)
Table 61. Monteris Medical, Inc. Key News & Latest Developments
Table 62. Novocure GmbH Company Summary
Table 63. Novocure GmbH Renal Cell Carcinoma Therapy Devices Product Offerings
Table 64. Novocure GmbH Renal Cell Carcinoma Therapy Devices Revenue (US$, Mn) & (2018-2023)
Table 65. Novocure GmbH Key News & Latest Developments
Table 66. Varian Medical Systems, Inc. Company Summary
Table 67. Varian Medical Systems, Inc. Renal Cell Carcinoma Therapy Devices Product Offerings
Table 68. Varian Medical Systems, Inc. Renal Cell Carcinoma Therapy Devices Revenue (US$, Mn) & (2018-2023)
Table 69. Varian Medical Systems, Inc. Key News & Latest Developments
List of Figures
Figure 1. Renal Cell Carcinoma Therapy Devices Segment by Type in 2022
Figure 2. Renal Cell Carcinoma Therapy Devices Segment by Application in 2022
Figure 3. Global Renal Cell Carcinoma Therapy Devices Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Renal Cell Carcinoma Therapy Devices Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Renal Cell Carcinoma Therapy Devices Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Renal Cell Carcinoma Therapy Devices Revenue in 2022
Figure 8. By Type - Global Renal Cell Carcinoma Therapy Devices Revenue Market Share, 2018-2030
Figure 9. By Application - Global Renal Cell Carcinoma Therapy Devices Revenue Market Share, 2018-2030
Figure 10. By Type - Global Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Renal Cell Carcinoma Therapy Devices Revenue Market Share, 2018-2030
Figure 12. By Application - Global Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Renal Cell Carcinoma Therapy Devices Revenue Market Share, 2018-2030
Figure 14. By Region - Global Renal Cell Carcinoma Therapy Devices Revenue Market Share, 2018-2030
Figure 15. By Country - North America Renal Cell Carcinoma Therapy Devices Revenue Market Share, 2018-2030
Figure 16. US Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Renal Cell Carcinoma Therapy Devices Revenue Market Share, 2018-2030
Figure 20. Germany Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 21. France Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Renal Cell Carcinoma Therapy Devices Revenue Market Share, 2018-2030
Figure 28. China Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 32. India Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Renal Cell Carcinoma Therapy Devices Revenue Market Share, 2018-2030
Figure 34. Brazil Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Renal Cell Carcinoma Therapy Devices Revenue Market Share, 2018-2030
Figure 37. Turkey Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Renal Cell Carcinoma Therapy Devices Revenue, (US$, Mn), 2018-2030
Figure 41. AngioDynamics, Inc. Renal Cell Carcinoma Therapy Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Boston Scientific Corporation (Galil Medical, Inc.) Renal Cell Carcinoma Therapy Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. IceCure Medical Renal Cell Carcinoma Therapy Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. HealthTronics, Inc. Renal Cell Carcinoma Therapy Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. HistoSonics, Inc. Renal Cell Carcinoma Therapy Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Integra LifeSciences Holdings Corporation Renal Cell Carcinoma Therapy Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Medtronic plc Renal Cell Carcinoma Therapy Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Monteris Medical, Inc. Renal Cell Carcinoma Therapy Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Novocure GmbH Renal Cell Carcinoma Therapy Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Varian Medical Systems, Inc. Renal Cell Carcinoma Therapy Devices Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
